Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue

The following table represents Evolent’s Services segment revenue disaggregated by type of services (in thousands), excluding revenues from our True Health segment and from our downside risk sharing arrangements through our insurance subsidiary, which are accounted for under ASC 944, Financial Services-Insurance.

	For the Three Months Ended March 31,
	2020		2019
Services Revenue
Transformation services	$	5,238	$	3,353
Platform and operations services
Clinical solutions	159,836		96,631
Administrative solutions	50,025		50,661

Contract with customer, asset and liability

The following table provides information about receivables, contract assets and deferred revenue from contracts with customers (in thousands):

	March 31, 2020		December 31, 2019
Short-term receivables (1)	$	105,019	$	71,707
Long-term receivables (1)	724		709
Short-term contract assets	1,752		1,751
Long-term contract assets	860		999
Short-term deferred revenue	17,023		19,828
Long-term deferred revenue	1,494		1,330

⁽¹⁾ Excludes pharmacy claims receivable and premiums receivable

Changes in contract assets and deferred revenue for the three months ended March 31, 2020, are as follows (in thousands):

	For the Three Months Ended March 31, 2020
Contract assets
Balance as of beginning-of-period	$	2,750
Reclassification to receivables, as the right to consideration becomes unconditional	(246		)
Contract assets recognized, net of reclassification to receivables	108
Balance as of end-of-period	$	2,612
Deferred revenue
Balance as of beginning-of-period	$	21,158
Reclassification to revenue, as a result of performance obligations satisfied	(12,529		)
Cash received in advance of satisfaction of performance obligations	9,888
Balance as of end-of-period	$	18,517